title: Synergy between chemotherapy and cancer vaccination.
authors.affiliation: Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre (LUMC), the Netherlands.
authors.forename: Tetje C
authors.initials: TC
authors.lastname: van der Sluis
authors.affiliation: Department of Clinical Oncology, Leiden University Medical Centre (LUMC), the Netherlands.
authors.forename: Sjoerd H
authors.initials: SH
authors.lastname: van der Burg
authors.affiliation: Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre (LUMC), the Netherlands.|ISA Pharmaceuticals, Leiden, the Netherlands.
authors.forename: Cornelis J
authors.initials: CJ
authors.lastname: Melief
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000097:blood; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D017209:Apoptosis / Q000276:immunology / Q000502:physiology; D018414:CD8-Positive T-Lymphocytes / Q000502:physiology; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology*; D002945:Cisplatin / Q000008:administration & dosage / Q000494:pharmacology; D004357:Drug Synergism; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D051379:Mice; D027383:Papillomaviridae / Q000276:immunology; D010455:Peptides / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D010455:Peptides; D014409:Tumor Necrosis Factor-alpha; D002945:Cisplatin